Loading insider details...
Latest Form 4 (Jul 22, 2026): Exercise/Conversion of 3,506 AKTS shares, $280.48.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 22, 2026 | Aktis Oncology, Inc. (AKTS) | Exercise/Conversion | 3,506 | $280.48 |
| Jul 20, 2026 | Aktis Oncology, Inc. (AKTS) | Exercise/Conversion | 3,065 | $245.20 |